Manuscripts
Showing 1546 manuscripts.
HIV-1 reservoir size after neonatal antiretroviral therapy and the potential to evaluate antiretroviral-therapy-free remission (IMPAACT P1115): a phase 1/2 proof-of-concept study
Citation
Mark F Cotton, Patrick Jean-Philippe, Anne Coletti, Ellen G Chadwick, Jennifer Jao, Stephen A Spector, Mark Mirochnick, Edmund V Capparelli, Diane Costello, Joseph Szewczyk, Nicol Nicodimus, Lynda Stranix-Chibanda, Adeodata R Kekitiinwa, Violet Korutaro, Deborah Persaud, Christina Reding, Yvonne Bryson, Mary N Carrington, Bryan S Nelson, Sai Majji, Camlin Tierney, Dwight E Yin. HIV-1 reservoir size after neonatal antiretroviral therapy and the potential to evaluate antiretroviral-therapy-free remission (IMPAACT P1115): a phase 1/2 proof-of-concept study. Lancet HIV. 2024. 23: 2352-3018. PMID: 38061376Year
2024
Journal
Lancet HIV
Study
P1115
Weight changes and adverse pregnancy outcomes with dolutegravir- and tenofovir alafenamide fumarate-containing antiretroviral treatment regimens during pregnancy and postpartum
Citation
Lauren Ziemba, Rebecca Zash, Lameck Chinula, Roger Shapiro, Jeffrey S A Stringer, Nahida Chakhtoura, Frances Nakayiwa, Ben Johnston, Avy Violari, Chelsea Krotje, Lee Fairlie, Katie McCarthy, Victoria Ndyanabangi, Patrick Jean-Philippe, Teacler G. Nematadzira, Paul Sax, Sherika Hanley, Judith S. Currier, Esau João, Shahin Lockman, Linda Aurpibul, VESTED Study Team, Mario Dias Correa Junior, Oranich Navanukroh, Neetal Nevrekar, Risa M. Hoffman, Gerhard Theron, Sean Brummel, Cristina Barroso Hofer. Weight changes and adverse pregnancy outcomes with dolutegravir- and tenofovir alafenamide fumarate-containing antiretroviral treatment regimens during pregnancy and postpartum. Clinical Infectious Diseases. 2024. ciae001PMID: 38180851Year
2024
Journal
Clinical Infectious Diseases
Study
IMPAACT 2010
Pharmacokinetics and Safety of Remdesivir in Pregnant and Non-Pregnant Women with COVID: Results from IMPAACT 2032
Citation
Sharon Nachman, Frederic Bone, Jennifer Jao, Kira Bacon, Murli Purswani, Benjamin Johnston, Allison Agwu, Christina Reding, Christy Beneri, Kathryn Kersey, Jaime G. Deville, Rita Humeniuk, Kathleen Powis, Brookie M. Best, Alice M. Stek, Mark Mirochnick, Ahizechukwu Eke, Jeremiah D. Momper, David E. Shapiro, IMPAACT 2032 Study Team, Edmund Capparelli, Elizabeth Greene, Kathleen George, Kristina M. Brooks, Dwight E. Yin, Kristin Baltrusaitis, Patrick Jean-Philippe, Diana F. Clarke, Nahida Chakhtoura. Pharmacokinetics and Safety of Remdesivir in Pregnant and Non-Pregnant Women with COVID: Results from IMPAACT 2032. Journal of Infectious Diseases. 2024. 230: 878-888. PMID: 38839047Year
2024
Journal
Journal of Infectious Diseases
Study
IMPAACT 2032
Impact of in-utero exposure to HIV and latent TB on infant humoral responses
Citation
Jyoti Mathad, Grace Montepiedra, Amita Gupta, Savita Pahwa, Kimberly J.S. Hjelmar, Lesley R. de Armas, Evan Goldberg, Suresh Pallikkuth. Impact of in-utero exposure to HIV and latent TB on infant humoral responses. Frontiers in Immunology. 2024. 15: 1423435. PMID: 38994354Year
2024
Journal
Frontiers in Immunology
Study
P1078
Characterising HIV drug resistance in cases of vertical transmission in the VESTED randomized antiretroviral treatment trial
Citation
Kevin Knowles, Lauren Ziemba, Sean Bremmel, Anne Coletti, Patrick Jean Philippe, Nahida Chakhtoura, Tichaona Vhembo, Haseena Cassim, Maxensia Owor, Lee Fairlie, Sikhulile Moyo, Violet Korutaro, Lameck Chinula, Marley D. Bishop, Shahin Lockman, Ceejay L. Boyce, Lisa M. Frenkel, Ingrid A. Beck, IMPAACT 2010 Team, Sheila M. Styrchak. Characterising HIV drug resistance in cases of vertical transmission in the VESTED randomized antiretroviral treatment trial. Journal of International AIDS Society. 2024. 96: 385-392. PMID: 39175843Year
2024
Journal
Journal of International AIDS Society
Study
IMPAACT 2010
Dolutegravir- Versus Efavirenz-Based Treatment in Pregnancy: Impact on Red Blood Cell Folate Concentrations in Pregnant Women and Their Infants
Citation
Benjamin Johnston, Terence Mohammed, Tichaona Vhembo, Enid Kabugho, Gerald Agaba Muzorah, Haseena Cassim, Lee Fairlie, Elizabeth S. Machado, Denise L. Jacobson, James S. Ngocho, Krista S. Crider, Roger L. Shapiro, Patricia DeMarrais, Lena Serghides, Sean Brummel, Nahida Chakhtoura, Mindy Zhang, Lameck Chinula, Christine M. Pfeiffer, Shahin Lockman, Cynthia A. Moore, Katie McCarthy. Dolutegravir- Versus Efavirenz-Based Treatment in Pregnancy: Impact on Red Blood Cell Folate Concentrations in Pregnant Women and Their Infants. Journal of Infectious Diseases. 2024. 230: 1224-1234. PMID: 38877762Year
2024
Journal
Journal of Infectious Diseases
Study
IMPAACT 2010
Markers of maternal bone and renal toxicity through 50 weeks postpartum: IMPAACT 2010 (VESTED) Trial
Citation
Laarni Igawa, Paul E. Sax, Anne Coletti, Lynda Stranix-Chibanda, Dorinda Mukura, IMPAACT 2010/VESTED study team and investigators, Lindie Rossouw, Gerhard Theron, Chelsea Krotje, Patrick Jean-Philippe, Nahida Chakhtoura, Haseena Cassim, Sisinyana Ruth Mathiba, Joel Maena, Gaerolwe Masheto, William Murtaugh, Sean S Brummel, Lee Fairlie, Lauren Ziemba, Judith Currier, John Shepherd, Risa Hoffman, Tapiwa Mbengeranwa, Lameck Chinula. Markers of maternal bone and renal toxicity through 50 weeks postpartum: IMPAACT 2010 (VESTED) Trial. Journal of Acquired Immune Deficiency Syndromes. 2024. 97: 172-179. PMID: 39250651Year
2024
Journal
Journal of Acquired Immune Deficiency Syndromes
Study
IMPAACT 2010
Effects of combination antiretroviral therapy and nutritional rehabilitation on growth in children aged 6-36 months with severe acute malnutrition in IMPAACT protocol P1092
Citation
Christina Reding, Frederic Bone, Sarah Bradford, Diane Costello, Renee Browning, John Moye, Tichaona Vhembo, Sharon Mambiya, Esnath Msowoya, Maxensia Owor, Philippa Musoke, Blandina Theophil Mmbaga, James Samwel Ngocho, Camlin Tierney, Lauren Ziemba. Effects of combination antiretroviral therapy and nutritional rehabilitation on growth in children aged 6-36 months with severe acute malnutrition in IMPAACT protocol P1092. Journal of Paediatric Infectious Diseases. 2024. PMID: 38808862Year
2024
Journal
Journal of Paediatric Infectious Diseases
Study
P1092
Acceptability and tolerability of long-acting injectable cabotegravir or rilpivirine in the first cohort of virologically suppressed adolescents living with HIV (IMPAACT 2017/MOCHA): a secondary analysis of a phase 1/2, multicentre, open-label, non-comparative dose-finding study
Citation
Kristin Baltrusaitis, Jenny Huang, Barbara Heckman, Sarah Buisson, Dwight E. Yin, Ryan Milligan, Allison Agwu, Shawn Ward, Rohan Hazra, Carolyn Bolton-Moore, Conn Harrington, Aditya H. Gaur, Rodica M. Van Solingen-Ristea, IMPAACT 2017 Team, Cynthia C. McCoig, Adeola Adeyeye, Jared Kneebone, Vasiliki Chounta, Christiana Smith-Anderson, Elizabeth D. Lowenthal, Andres Camacho-Gonzalez, Jennifer Chapman, Ellen Chadwick, Rachel Ohrenschall, Allison Bearden, Katherine Calabrese, Herta Crauwels. Acceptability and tolerability of long-acting injectable cabotegravir or rilpivirine in the first cohort of virologically suppressed adolescents living with HIV (IMPAACT 2017/MOCHA): a secondary analysis of a phase 1/2, multicentre, open-label, non-comparative dose-finding study. Lancet HIV. 2024. 11: e222-e232. PMID: 38538161Year
2024
Journal
Lancet HIV
Study
IMPAACT 2017
Subsequent pregnancies in the IMPAACT 2010/VESTED Trial: high rate of adverse outcomes in women living with HIV
Citation
Roger Shapiro, Jeff Stringer, Grace Malonga, Renee Browning, Nahida Chakhtoura, Blandina Theophil Mmbaga, Tsungai P Mhembere, Ayotunde Omoz-Oarhe, Beatrice Nagaddya, Megeshinee Naidoo, Risa M Hoffman, Lee Fairlie, Shahin Lockman, Sean Brummel, IMPAACT 2010/VESTED Study Team, Lauren Ziemba, Anne Coletti, Lameck Chinula. Subsequent pregnancies in the IMPAACT 2010/VESTED Trial: high rate of adverse outcomes in women living with HIV. Journal of the International AIDS Society. 2024. 97: 150-155. PMID: 39742354Year
2024
Journal
Journal of the International AIDS Society
Study
IMPAACT 2010